Quince Therapeutics, Inc. (QNCX)
QNCX Stock Price Chart
Explore Quince Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze QNCX price movements and trends.
QNCX Company Profile
Discover essential business fundamentals and corporate details for Quince Therapeutics, Inc. (QNCX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 May 2019
Employees
36.00
Website
https://www.quincetx.comCEO
Dirk Thye
Description
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
QNCX Financial Timeline
Browse a chronological timeline of Quince Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.20.
Earnings released on 11 Aug 2025
EPS came in at -$0.34 falling short of the estimated -$0.28 by -21.43%.
Earnings released on 13 May 2025
EPS came in at -$0.34 falling short of the estimated -$0.24 by -41.67%.
Earnings released on 24 Mar 2025
EPS came in at -$0.28 falling short of the estimated -$0.19 by -47.37%.
Earnings released on 13 Nov 2024
EPS came in at -$0.13 surpassing the estimated -$0.15 by +13.33%.
Earnings released on 13 Aug 2024
EPS came in at -$0.18 .
Earnings released on 1 Apr 2024
EPS came in at -$0.21 .
Earnings released on 14 Feb 2024
EPS came in at -$0.22 surpassing the estimated -$0.28 by +21.43%, while revenue for the quarter reached $36.00K .
Earnings released on 14 Nov 2023
EPS came in at -$0.15 .
Earnings released on 3 Aug 2023
EPS came in at -$0.14 .
Earnings released on 15 May 2023
EPS came in at -$0.34 falling short of the estimated -$0.31 by -9.95%.
Earnings released on 15 Mar 2023
EPS came in at -$0.13 surpassing the estimated -$0.29 by +54.80%.
Earnings released on 9 Nov 2022
EPS came in at -$0.22 surpassing the estimated -$0.28 by +21.43%.
Earnings released on 9 Aug 2022
EPS came in at -$0.51 surpassing the estimated -$0.74 by +31.08%.
Earnings released on 10 May 2022
EPS came in at -$0.72 falling short of the estimated -$0.55 by -30.91%.
Earnings released on 1 Mar 2022
EPS came in at -$0.78 falling short of the estimated -$0.65 by -20.00%.
Earnings released on 29 Oct 2021
EPS came in at -$0.73 surpassing the estimated -$0.74 by +1.35%.
Earnings released on 6 Aug 2021
EPS came in at -$0.74 surpassing the estimated -$0.76 by +2.63%.
Earnings released on 6 May 2021
EPS came in at -$0.78 falling short of the estimated -$0.72 by -8.33%.
Earnings released on 1 Mar 2021
EPS came in at -$0.69 surpassing the estimated -$0.73 by +5.48%.
Earnings released on 12 Nov 2020
EPS came in at -$0.73 falling short of the estimated -$0.62 by -17.74%.
QNCX Stock Performance
Access detailed QNCX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.